# Mendelian Reverse Cholesterol Transport Study

> **NCT01782027** · NA · TERMINATED · sponsor: **University of Pennsylvania** · enrollment: 17 (actual)

## Conditions studied

- Cholesterol, HDL
- Lipid Metabolism, Inborn Errors
- Tangier Disease
- LCAT Deficiency
- Cholesteryl Ester Transfer Protein (CETP) Deficiency

## Interventions

- **DRUG:** 3H-cholesterol bound to albumin

## Key facts

- **NCT ID:** NCT01782027
- **Lead sponsor:** University of Pennsylvania
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-10
- **Primary completion:** 2024-09-04
- **Final completion:** 2024-09-04
- **Target enrollment:** 17 (ACTUAL)
- **Why stopped:** Lack of funding
- **Last updated:** 2024-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01782027

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01782027, "Mendelian Reverse Cholesterol Transport Study". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01782027. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*